Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ph Nuss

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
L'Encephale|December 23, 2008
[Neurologic symptoms in schizophrenia]Ph Nuss, F Ferreri, C Agbokou, et al.
Journal of Affective Disorders|April 8, 2016
Early effect on general interest, and short-term antidepressant efficacy and safety of agomelatine (25-50mg/day) and escitalopram (10-20mg/day) in outpatients with Major Depressive Disorder. A 12-week randomised double-blind comparative studyT Udristoiu, P Dehelean, Ph Nuss, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
L'Encephale|December 23, 2008
[Neurologic symptoms in schizophrenia]Ph Nuss, F Ferreri, C Agbokou, et al.
Journal of Affective Disorders|April 8, 2016
Early effect on general interest, and short-term antidepressant efficacy and safety of agomelatine (25-50mg/day) and escitalopram (10-20mg/day) in outpatients with Major Depressive Disorder. A 12-week randomised double-blind comparative studyT Udristoiu, P Dehelean, Ph Nuss, et al.
Pageof 1